Y-Intercept (Hong Kong) Ltd

Position in ANNX — Annexon, Inc.

CIK 1772875 HONG KONG, K3

Position in ANNX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$7,312,318

+$7,185,097 QoQ

Shares Held

1,319,913

+1902.4% QoQ

Ownership

0.661%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#25

of 216 holders

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $167,724,147 across 89 Biotechnology names. ANNX ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	35,829	$15,999,081
2	ADMA	Adma Biologics, Inc.	1,075,422	$9,689,552
3	UPB	Upstream Bio, Inc.	1,000,631	$9,005,679
4	ANNX	Annexon, Inc. This page	1,319,913	$7,312,318
5	XENE	Xenon Pharmaceuticals Inc.	85,388	$4,965,312
6	RARE	Ultragenyx Pharmaceutical Inc.	218,354	$4,574,516
7	INCY	Incyte Corp	47,833	$4,502,041
8	BMRN	Biomarin Pharmaceutical Inc	78,338	$4,425,313

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,312,318	1,319,913	+1902.4%	Shares	Sole	2026-04-27
2025-03-31	$127,221	65,918	—	Shares	Sole	2025-05-06
No filing history on record for this holder in this stock.